Abstract:Background Clinical prediction models have been developed for hospitalization for heart failure in type 2 diabetes. However, a systematic evaluation of these models' performance, applicability, and clinical impact is absent. Methods and Results We searched Embase, MEDLINE, Web of Science, Google Scholar, and Tufts' clinical prediction registry through February 2021. Studies needed to report the development, validation, clinical impact, or update of a prediction model for hospitalization for heart failure in type 2 diabetes with measures of model performance and sufficient information for clinical use. Model assessment was done with the Prediction Model Risk of Bias Assessment Tool, and meta‐analyses of model discrimination were performed. We included 15 model development and 3 external validation studies with data from 999 167 people with type 2 diabetes. Of the 15 models, 6 had undergone external validation and only 1 had low concern for risk of bias and applicability (Risk Equations for Complications of Type 2 Diabetes). Seven models were presented in a clinically useful manner (eg, risk score, online calculator) and 2 models were classified as the most suitable for clinical use based on study design, external validity, and point‐of‐care usability. These were Risk Equations for Complications of Type 2 Diabetes (meta‐analyzed c‐statistic, 0.76) and the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes (meta‐analyzed c‐statistic, 0.78), which was the simplest model with only 5 variables. No studies reported clinical impact. Conclusions Most prediction models for hospitalization for heart failure in patients with type 2 diabetes have potential concerns with risk of bias or applicability, and uncertain external validity and clinical impact. Future research is needed to address these knowledge gaps. Nonstandard Abbreviations and Acronyms ACCORD Action to Control Cardiovascular Risk in Diabetes trial HHF hospitalization for heart failure PROBAST Prediction Model Risk of Bias Assessment Tool RECODe Risk Equations for Complications of Type 2 Diabetes TRS‐HF DM Thrombolysis in Myocardial Infarction Risk Score for HF in Diabetes WATCH‐DM (Weight [BMI], Age, Hypertension, Creatinine, HDL‐C, Diabetes Control [fasting plasma glucose], QRS Duration, MI, and CABG) risk score Clinical Perspective What Is New? Available evidence suggests that several widely available clinical risk tools can robustly prognosticate the risk of heart failure hospitalization in people with type 2 diabetes and identify those who may benefit most from novel guideline‐directed medical therapies. The effect of most clinical prediction models on clinical outcomes, patient care, provider behaviors has largely been under investigated, as a result, health, economic, and clinical investigations of these tools are warranted. What Are the Clinical Implications? Given that several clinical prediction models have demonstrated robust prognostic accuracy, their implementation in clinical settings might facilitate the identification of high‐risk individuals with type 2 diabetes who may benefit most from guideline‐directed therapies such as sodium‐glucose co‐transporter 2 inhibitors. Type 2 diabetes (T2D) contributes to >1.5 million annual deaths worldwide. 1 This high rate of mortality can be partly attributed to the metabolic alterations that precipitate diabetic cardiomyopathy and its attendant complications. 2 Correspondingly, the development of heart failure (HF) has emerged as one of the most common and important manifestations of cardiovascular disease in individuals with diabetes. 3 The concern over HF initially stemmed from safety troubles with certain antidiabetic treatments (eg, thiazolidinediones), and the fact that hospitalizations for heart failure (HHF) portend a poor prognosis. 4 , 5 Thus, the use of prediction models for identifying patients with diabetes at particularly high risk for developing HF -Abstract Truncated-

Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction

Progression of Heart Failure in People with Type 2 Diabetes in Germany: An Analysis Using German Health Insurance Claims Data

Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study

Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression

Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction

Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study

Heart Failure with Preserved Ejection Fraction (hfpef) in Type 2 Diabetes Mellitus: from Pathophysiology to Therapeutics

Heart Failure and Diabetes: Clinical significance and epidemiology of this two‐way association

Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry

The underestimated risk of prediabetes on cardiovascular outcomes in heart failure with reduced left ventricular function

Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction

Premature Mortality in Type 2 Diabetes Mellitus Associated with Heart Failure and Chronic Kidney Disease: 20 Years of Real-World Data

Epidemiology of heart failure in diabetes: a disease in disguise

Association between prediabetes and adverse outcomes in heart failure

Heart Failure Patients with type II diabetes still require more focus

Changes over time in the association between type 2 diabetes and post-discharge outcomes in decompensated chronic heart failure patients: Findings from the RICA Registry

Predicting and preventing heart failure in type 2 diabetes

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial

A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management